Re: Patented formulation US 7,855,196 B2 Date dec 21 2010 and Canadian Patent Pending no: 2,556,163

Summary:
A composition comprising a benzodiazepine agonist, a benzodiazepine antagonist, and a pharmaceutical acceptable carrier in a effective ratio so as to preserve the therapeutic effects of the benzodiazepine agonist while modulating side effects of the benzodiazepine agonist

The invention provides a composition in a appropriate ratio to prevent tolerance, side effects (sedation, muscle relaxant and withdrawal symptoms by the patient while preserving the therapeutic benefits of the benzodiazepine agonist (anxiolysis, anticonvulsivant, pain control) and allowing an higher dosage of the latter

Full Description:
A composition comprising a benzodiazepine agonist, a benzodiazepine antagonist, and a pharmaceutical acceptable carrier in a effective ratio so as to preserve the therapeutic effects of the benzodiazepine agonist while modulating side effects of the benzodiazepine agonist

The invention provides a composition in a appropriate ratio to prevent tolerance, side effects (sedation, muscle relaxant and withdrawal symptoms by the patient while preserving the therapeutic benefits of the benzodiazepine agonist (anxiolysis, anticonvulsivant, pain control) and allowing an higher dosage of the latter

Problem this idea/invention addresses:
CHRONIC NEUROPATHIC PAIN AS A PRIMARY INDICATION AND TINNITUS AS A SECONDARY INDICATION

Patent: US 78,551,962

Asking price: [CONTACT SELLER]
Available for consultation? Yes

Invention #11666
Date posted: 2011-03-30

Contact the Inventor

« More Medical Inventions